CAPUOZZO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 397
EU - Europa 258
AS - Asia 208
AF - Africa 22
SA - Sud America 8
OC - Oceania 6
Totale 899
Nazione #
US - Stati Uniti d'America 394
IT - Italia 166
SG - Singapore 86
CN - Cina 51
HK - Hong Kong 37
DE - Germania 26
VN - Vietnam 20
IE - Irlanda 18
CI - Costa d'Avorio 17
FI - Finlandia 13
NL - Olanda 12
RU - Federazione Russa 12
BR - Brasile 8
TR - Turchia 8
AU - Australia 6
MA - Marocco 5
SE - Svezia 4
CA - Canada 3
IN - India 3
FR - Francia 2
JP - Giappone 2
DK - Danimarca 1
ES - Italia 1
GB - Regno Unito 1
KR - Corea 1
RS - Serbia 1
SI - Slovenia 1
Totale 899
Città #
Chandler 86
Singapore 63
Napoli 47
Hong Kong 37
Ashburn 27
Dong Ket 20
Millbury 16
Milan 15
Princeton 15
Santa Clara 15
Beijing 14
Des Moines 13
Nanjing 12
Naples 12
Amsterdam 11
Boston 9
Redwood City 7
Casablanca 5
Sydney 5
Hebei 4
Jiaxing 4
Nanchang 4
Seattle 4
Shenyang 4
Çanakkale 4
Ottawa 3
Pune 3
Tianjin 3
Bologna 2
Helsinki 2
Lawrence 2
Rende 2
Salerno 2
Wilmington 2
Angri 1
Belgrade 1
Belo Horizonte 1
Brusciano 1
Bursa 1
Casagiove 1
Caserta 1
Castiglione Delle Stiviere 1
Catalão 1
Catania 1
Cava De' Tirreni 1
Changsha 1
Cicciano 1
Cândido Mota 1
Eboli 1
Fairfield 1
Falkenstein 1
Florence 1
Formia 1
Galatone 1
Gessate 1
Hefei 1
Indiana 1
Istanbul 1
Jinan 1
Kirrawee 1
La Jolla 1
Limatola 1
Ljubljana 1
Madrid 1
Maricá 1
Mercogliano 1
New York 1
Nürnberg 1
Ottaviano 1
Portici 1
Recife 1
Rome 1
Salandra 1
Salvador 1
San Giorgio Del Sannio 1
Santa Barbara 1
Selargius 1
Serre 1
Shenzhen 1
Siano 1
Simi Valley 1
São Bernardo do Campo 1
São José dos Campos 1
Yellow Springs 1
Totale 524
Nome #
Cysteine Prevents the Reduction in Keratin Synthesis Induced by Iron Deficiency in Human Keratinocytes 85
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action. 83
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 75
"dressing up" an Old Drug: An Aminoacyl Lipid for the Functionalization of Ru(III)-Based Anticancer Agents 70
Lipooligosaccharides as Amphiphiles to Build Liposomes for Effective Drug Delivery: The Case of Anticancer Ruthenium Complex-Based Aggregates 66
Novel Non-Peptide Small Molecules Preventing IKKβ/NEMO Association Inhibit NF-κB Activation in LPS-Stimulated J774 Macrophages 62
Cationic liposomes as efficient nanocarriers for the drug delivery of an anticancer cholesterol-based ruthenium complex 61
Cytotoxicity of seven bisphenol analogues compared to bisphenol A and relationships with membrane affinity data 61
Ruthenium-based nanovectors for cancer therapy 56
Expanding the potential of G-quadruplex structures: formation of a heterochiral TBA analogue 52
A ruthenium anticancer compound interacts with histones and impacts differently on epigenetic and death pathways compared to cisplatin 50
In vitro bioactivity of ruthenium-based multifunctional nucleolipidic liposomes: new promising agents for cancer therapy 48
A straightforward modification in the thrombin binding aptamer improving stability, affinity to thrombin and nuclease resistance 47
Endocrine distruptors: bisphenols citotoxicity and effects on cellular iron homeostasis 47
Glucose deprivation promotes activation of mTOR signaling pathway and protein synthesis in rat skeletal muscle cells. 45
Nucleolipidic-based liposomes effectively deliver a Ru(III) complex across cell membranes to nuclei promoting in concert apoptosis and autophagy in human models of breast cancer 45
Fluoxetine ameliorates mucopolysaccharidosis type IIIA 34
Totale 987
Categoria #
all - tutte 3.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.741


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 0 0 0 0 0 0 0 3 7 5 7 1
2020/202177 5 0 1 1 6 10 2 1 29 0 1 21
2021/2022119 0 0 0 3 1 6 0 4 18 12 33 42
2022/2023187 24 23 10 16 13 25 1 12 31 16 14 2
2023/2024103 1 18 10 2 4 20 8 20 1 0 18 1
2024/2025185 28 34 0 9 6 24 62 22 0 0 0 0
Totale 987